INTRODUCTION
• Lichen planus (LP) is an inflammatory T-cell mediated
autoimmune disorder affecting skin , hair nail & mucous
membrane
 Key descriptive features – 4P
Purple
Polygonal
Pruritus
Papule
EPIDEMIOLOGY
Age 30 – 60
1 – 4 % patients are children
Men and women are equally affected
AETIOLOGY & PATHOGENESIS
• It’s not well understood
• Risk factors are
Viral infections
Autoimmune disorders
Medications
Vaccinations
Restorative dental materials
• Cell mediated immunity plays a major role in
triggering clinical manifestations
• T-cell mediated autoimmune damage to basal
keratinocytes occur and that manifest as altered self
antigens on their surface
TARGET ANTIGENS
o Virus – HCV & other TTV
o Vaccines – HBV vaccine
o Contact allergens – Mercury , Copper & Gold
o Drugs – Antimicrobials , Antihypertensive ,
Antidepressants , Diuretics , NSAIDs etc
HISTOLOGY
• Biopsy shows irregular acanthosis of epidermis with
hypergranulosis & compact hyperkeratosis
• Basal cell damage , colloid bodies , pigment
incontinence & band like lympho histioctic infiltrate
obscuring the dermo-epidermal interface are other typical
charecteristics
CLINICAL FEATURES
• Primary lesion are small , polygonal , red or violet , flat
topped papules or plaques
• Surface is slightly shiny or transparent & a network of
fine white lines called Wickham’s striae or small grey
white puncta is also seen
• Papules may be widely dispersed or they may coalesce to
form large plaques
• Intense itching is fairly consistand feature
• Koebner’s phenomenon can be seen
• Common sites are flexor aspect of wrist & forearm ,
dorsum of hands , anterior aspect of lower limbs & neck
and pre sacral areas
• Face is usually spared
• Palmo-plantar involvement is unusual
• LP heals with hyperpigmentation
CLINICAL VARIETIES
CONFIGURATION
Annular
Linear
MORPHOLOGY
Hypertrophic
Atrophic
Vesiculo-bullous
Follicular
• Actinic – central hyperpigmentation and surrounding rim
of hypopigmentation
• Lichen planus pigmentosis – hyperpigmented dark
brown macules in sun exposed parts
SITE
Mucosal LP
Nail LP
Mucosal LP
Constitute 30 – 70 % of cases
With or without skin lesions
Seen in oral cavity , vagina , esophagus , conjunctiva ,
urethra , nose , anus & larynx
Reticular , plaque like , atrophic , papular , erosive ,
ulcerative and bullous form
Reticular lacy white pattern
Nail LP
Constitute 10 – 15 % of cases
Thinning , longitudinal ridging & distal splitting of
nail plate occurs
Forward growth of proximal nail fold (pterygium) with
adherence to proximal nail plate is classic sign
DIFFERENTIAL DIAGNOSIS
Cutaneous LP – Pityriasis rosea , Guttate psoriasis ,
Secondary syphilis & Lichenoid drug eruption
Mucosal LP – Candidiasis , Aphthous stomatitis
Pemphigus & Secondary syphilis
Nail LP – Psoriasis & Onychomycosis
TREATMENT
TOPICAL
Calamine lotion
Steroids (creams or intra lesional )
Retinoid
Tacrolimus
Topical lignocaine and beteamethasone mouth wash can
be used in oral LP
SYSTEMIC
Anti histamines ( to reduce pruritus )
Systemic corticosteroids
Dapsone
Systemic retinoid
Methotrexate
Phototherapy
Lichen planus

Lichen planus

  • 2.
    INTRODUCTION • Lichen planus(LP) is an inflammatory T-cell mediated autoimmune disorder affecting skin , hair nail & mucous membrane  Key descriptive features – 4P Purple Polygonal Pruritus Papule
  • 3.
    EPIDEMIOLOGY Age 30 –60 1 – 4 % patients are children Men and women are equally affected
  • 4.
    AETIOLOGY & PATHOGENESIS •It’s not well understood • Risk factors are Viral infections Autoimmune disorders Medications Vaccinations Restorative dental materials
  • 5.
    • Cell mediatedimmunity plays a major role in triggering clinical manifestations • T-cell mediated autoimmune damage to basal keratinocytes occur and that manifest as altered self antigens on their surface
  • 6.
    TARGET ANTIGENS o Virus– HCV & other TTV o Vaccines – HBV vaccine o Contact allergens – Mercury , Copper & Gold o Drugs – Antimicrobials , Antihypertensive , Antidepressants , Diuretics , NSAIDs etc
  • 7.
    HISTOLOGY • Biopsy showsirregular acanthosis of epidermis with hypergranulosis & compact hyperkeratosis • Basal cell damage , colloid bodies , pigment incontinence & band like lympho histioctic infiltrate obscuring the dermo-epidermal interface are other typical charecteristics
  • 9.
    CLINICAL FEATURES • Primarylesion are small , polygonal , red or violet , flat topped papules or plaques • Surface is slightly shiny or transparent & a network of fine white lines called Wickham’s striae or small grey white puncta is also seen • Papules may be widely dispersed or they may coalesce to form large plaques • Intense itching is fairly consistand feature
  • 10.
    • Koebner’s phenomenoncan be seen • Common sites are flexor aspect of wrist & forearm , dorsum of hands , anterior aspect of lower limbs & neck and pre sacral areas • Face is usually spared • Palmo-plantar involvement is unusual • LP heals with hyperpigmentation
  • 12.
  • 13.
    • Actinic –central hyperpigmentation and surrounding rim of hypopigmentation • Lichen planus pigmentosis – hyperpigmented dark brown macules in sun exposed parts SITE Mucosal LP Nail LP
  • 14.
    Mucosal LP Constitute 30– 70 % of cases With or without skin lesions Seen in oral cavity , vagina , esophagus , conjunctiva , urethra , nose , anus & larynx Reticular , plaque like , atrophic , papular , erosive , ulcerative and bullous form
  • 15.
  • 18.
    Nail LP Constitute 10– 15 % of cases Thinning , longitudinal ridging & distal splitting of nail plate occurs Forward growth of proximal nail fold (pterygium) with adherence to proximal nail plate is classic sign
  • 21.
    DIFFERENTIAL DIAGNOSIS Cutaneous LP– Pityriasis rosea , Guttate psoriasis , Secondary syphilis & Lichenoid drug eruption Mucosal LP – Candidiasis , Aphthous stomatitis Pemphigus & Secondary syphilis Nail LP – Psoriasis & Onychomycosis
  • 22.
    TREATMENT TOPICAL Calamine lotion Steroids (creamsor intra lesional ) Retinoid Tacrolimus Topical lignocaine and beteamethasone mouth wash can be used in oral LP
  • 23.
    SYSTEMIC Anti histamines (to reduce pruritus ) Systemic corticosteroids Dapsone Systemic retinoid Methotrexate Phototherapy